253 related articles for article (PubMed ID: 29196603)
1. Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage.
Hsu SC; Nadesan P; Puviindran V; Stallcup WB; Kirsch DG; Alman BA
J Biol Chem; 2018 Feb; 293(7):2466-2475. PubMed ID: 29196603
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Tumors Can Derive from Ng2/Cspg4-Expressing Pericytes with β-Catenin Modulating the Neoplastic Phenotype.
Sato S; Tang YJ; Wei Q; Hirata M; Weng A; Han I; Okawa A; Takeda S; Whetstone H; Nadesan P; Kirsch DG; Wunder JS; Alman BA
Cell Rep; 2016 Jul; 16(4):917-927. PubMed ID: 27425618
[TBL] [Abstract][Full Text] [Related]
3. NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion.
Cattaruzza S; Nicolosi PA; Braghetta P; Pazzaglia L; Benassi MS; Picci P; Lacrima K; Zanocco D; Rizzo E; Stallcup WB; Colombatti A; Perris R
J Mol Cell Biol; 2013 Jun; 5(3):176-93. PubMed ID: 23559515
[TBL] [Abstract][Full Text] [Related]
4. CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes.
Leuci V; Donini C; Grignani G; Rotolo R; Mesiano G; Fiorino E; Gammaitoni L; D'Ambrosio L; Merlini A; Landoni E; Medico E; Capellero S; Giraudo L; Cattaneo G; Iaia I; Pignochino Y; Basiricò M; Vigna E; Pisacane A; Fagioli F; Ferrone S; Aglietta M; Dotti G; Sangiolo D
Clin Cancer Res; 2020 Dec; 26(23):6321-6334. PubMed ID: 32900797
[TBL] [Abstract][Full Text] [Related]
5. Functional roles of CSPG4/NG2 in chondrosarcoma.
Jamil NS; Azfer A; Worrell H; Salter DM
Int J Exp Pathol; 2016 Apr; 97(2):178-86. PubMed ID: 27292772
[TBL] [Abstract][Full Text] [Related]
6. The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas.
Schiffer D; Mellai M; Boldorini R; Bisogno I; Grifoni S; Corona C; Bertero L; Cassoni P; Casalone C; Annovazzi L
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213051
[TBL] [Abstract][Full Text] [Related]
7. Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality.
Tamburini E; Dallatomasina A; Quartararo J; Cortelazzi B; Mangieri D; Lazzaretti M; Perris R
FASEB J; 2019 Mar; 33(3):3112-3128. PubMed ID: 30550356
[TBL] [Abstract][Full Text] [Related]
8. Human melanoma/NG2 chondroitin sulfate proteoglycan is expressed in the sarcolemma of postnatal human skeletal myofibers. Abnormal expression in merosin-negative and Duchenne muscular dystrophies.
Petrini S; Tessa A; Carrozzo R; Verardo M; Pierini R; Rizza T; Bertini E
Mol Cell Neurosci; 2003 Jun; 23(2):219-31. PubMed ID: 12812755
[TBL] [Abstract][Full Text] [Related]
9. Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells.
Cooney CA; Jousheghany F; Yao-Borengasser A; Phanavanh B; Gomes T; Kieber-Emmons AM; Siegel ER; Suva LJ; Ferrone S; Kieber-Emmons T; Monzavi-Karbassi B
Breast Cancer Res; 2011 Jun; 13(3):R58. PubMed ID: 21658254
[TBL] [Abstract][Full Text] [Related]
10. CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma.
Rivera Z; Ferrone S; Wang X; Jube S; Yang H; Pass HI; Kanodia S; Gaudino G; Carbone M
Clin Cancer Res; 2012 Oct; 18(19):5352-63. PubMed ID: 22893632
[TBL] [Abstract][Full Text] [Related]
11. Furanodienone overcomes temozolomide resistance in glioblastoma through the downregulation of CSPG4-Akt-ERK signalling by inhibiting EGR1-dependent transcription.
Chen L; Liu YC; Zheng YY; Xu J; Zhang Y; Liu WL; Li ZY; Huang GD; Li WP
Phytother Res; 2019 Jun; 33(6):1736-1747. PubMed ID: 31006910
[TBL] [Abstract][Full Text] [Related]
12. Chondroitin sulfate proteoglycan protein is stimulated by interleukin 11 and promotes endometrial epithelial cancer cell proliferation and migration.
Winship A; Van Sinderen M; Heffernan-Marks A; Dimitriadis E
Int J Oncol; 2017 Mar; 50(3):798-804. PubMed ID: 28098860
[TBL] [Abstract][Full Text] [Related]
13. Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets.
Girolamo F; Dallatomasina A; Rizzi M; Errede M; Wälchli T; Mucignat MT; Frei K; Roncali L; Perris R; Virgintino D
PLoS One; 2013; 8(12):e84883. PubMed ID: 24386429
[TBL] [Abstract][Full Text] [Related]
14. Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas.
Mellai M; Annovazzi L; Bisogno I; Corona C; Crociara P; Iulini B; Cassoni P; Casalone C; Boldorini R; Schiffer D
Cells; 2020 Jun; 9(6):. PubMed ID: 32599896
[TBL] [Abstract][Full Text] [Related]
15. NG2 expression in NG2 glia is regulated by binding of SoxE and bHLH transcription factors to a Cspg4 intronic enhancer.
Gotoh H; Wood WM; Patel KD; Factor DC; Boshans LL; Nomura T; Tesar PJ; Ono K; Nishiyama A
Glia; 2018 Dec; 66(12):2684-2699. PubMed ID: 30306660
[TBL] [Abstract][Full Text] [Related]
16. Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia.
Pucciarelli D; Lengger N; Takacova M; Csaderova L; Bartosova M; Breiteneder H; Pastorekova S; Hafner C
Int J Oncol; 2015 Jul; 47(1):81-90. PubMed ID: 25997619
[TBL] [Abstract][Full Text] [Related]
17. CSPG4 Is a Potential Therapeutic Target in Anaplastic Thyroid Cancer.
Egan CE; Stefanova D; Ahmed A; Raja VJ; Thiesmeyer JW; Chen KJ; Greenberg JA; Zhang T; He B; Finnerty BM; Zarnegar R; Jin MM; Scognamiglio T; Dephoure N; Fahey T; Min IM
Thyroid; 2021 Oct; 31(10):1481-1493. PubMed ID: 34078123
[No Abstract] [Full Text] [Related]
18. CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response.
Boudin L; de Nonneville A; Finetti P; Mescam L; Le Cesne A; Italiano A; Blay JY; Birnbaum D; Mamessier E; Bertucci F
J Transl Med; 2022 Oct; 20(1):464. PubMed ID: 36221119
[TBL] [Abstract][Full Text] [Related]
19. Chondroitin sulfate proteoglycan 4: An attractive target for antibody-based immunotherapy.
Kurokawa T; Imai K
Proc Jpn Acad Ser B Phys Biol Sci; 2024; 100(5):293-308. PubMed ID: 38735753
[TBL] [Abstract][Full Text] [Related]
20. Candidate CSPG4 mutations and induced pluripotent stem cell modeling implicate oligodendrocyte progenitor cell dysfunction in familial schizophrenia.
de Vrij FM; Bouwkamp CG; Gunhanlar N; Shpak G; Lendemeijer B; Baghdadi M; Gopalakrishna S; Ghazvini M; Li TM; Quadri M; Olgiati S; Breedveld GJ; Coesmans M; Mientjes E; de Wit T; Verheijen FW; Beverloo HB; Cohen D; Kok RM; Bakker PR; Nijburg A; Spijker AT; Haffmans PMJ; Hoencamp E; Bergink V; ; Vorstman JA; Wu T; Olde Loohuis LM; Amin N; Langen CD; Hofman A; Hoogendijk WJ; van Duijn CM; Ikram MA; Vernooij MW; Tiemeier H; Uitterlinden AG; Elgersma Y; Distel B; Gribnau J; White T; Bonifati V; Kushner SA
Mol Psychiatry; 2019 May; 24(5):757-771. PubMed ID: 29302076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
